EUVIMEDEUVIMED entdecken
Crossref

Patient engagement in healthcare: a preliminary set of measures to evaluate patient engagement in the European Reference Networks.

Diana Marinello, Ilaria Galetti, Dorica Dan, Ammi Sundqvist Andersson, Silvia Aguilera, Simone Louisse, Lenja Wiehe, Anne-Laure Aslanian, Ines Hernando Martin

Rare Disease and Orphan Drugs Journal · 2022

DOI: 10.20517/rdodj.2021.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rare Disease and Orphan Drugs Journal, 2022. Verfasst von Diana Marinello und 8 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The European Reference Networks (ERNs) provide clinicians and patients the opportunity to collaborate at EU level to improve diagnosis, care and treatment for people living with rare and complex conditions. However, building a partnership culture to systematically involve patients in ERN activities and decision-making structures is challenging, partly because the role of patient representatives and the value of this collaboration are not always understood. The objective of this project was to develop an evaluation framework to assess the impact of patient engagement in the ERNs and to provide evidence on the value of patient-clinician partnership.

Methods

The evaluation was developed by EURORDIS and patient representatives involved in the ERNs (ePAG advocates) through a participatory and iterative process. The work was organised in three different phases: (1) clarify roles and identify common goals for ePAG advocates’ engagement in the ERNs; (2) define a set of measures; and (3) test the measures in three different ePAGs (European Patient Advocacy Groups).

Results

The project allowed developing a common understanding among ePAG advocates of their role and goals in the ERNs and defining a patient-driven evaluation framework to assess their level of engagement in the ERNs’ activities and how effectively they were working to fulfil their role.

Conclusion

Engaging with ERN clinicians to refine the framework would probably render it more relevant to the reality and priorities of the specific ERNs and more valuable as a tool to build a strong partnership culture. Such an evaluation framework could be integrated into the ERNs’ quality improvement system to ensure that the networks’ activities are driven by and remain responsive to patients’ needs.

Zitieren

APA

Marinello, D., Galetti, I., Dan, D., Andersson, A. S., Aguilera, S., Louisse, S., Wiehe, L., Aslanian, A., & Martin, I. H. (2022). Patient engagement in healthcare: a preliminary set of measures to evaluate patient engagement in the European Reference Networks. Rare Disease and Orphan Drugs Journal. https://doi.org/10.20517/rdodj.2021.001

Vancouver

Marinello D, Galetti I, Dan D, Andersson AS, Aguilera S, Louisse S, et al. Patient engagement in healthcare: a preliminary set of measures to evaluate patient engagement in the European Reference Networks. Rare Disease and Orphan Drugs Journal. 2022. doi:10.20517/rdodj.2021.001

BibTeX
@article{Marinello2022,
  author = {Marinello, Diana and Galetti, Ilaria and Dan, Dorica and Andersson, Ammi Sundqvist and Aguilera, Silvia and Louisse, Simone and Wiehe, Lenja and Aslanian, Anne-Laure and Martin, Ines Hernando},
  title = {Patient engagement in healthcare: a preliminary set of measures to evaluate patient engagement in the European Reference Networks},
  journal = {Rare Disease and Orphan Drugs Journal},
  year = {2022},
  doi = {10.20517/rdodj.2021.001}
}
Kostenlos starten →